Better For You Wellness Establishes Strategic Advisory Committee with Industry Leaders and More
Columbus, Ohio–(Newsfile Corp. – February 10, 2022) – Better For You Wellness, Inc. (OTCQB: BFYW) (“Better For You Wellness” or the “Company”), an Ohio-based company focused on the rapidly-growing $1.5T wellness industry, is pleased to announce the results of the Meeting of the Board of Directors that took place on February 5, 2022, via video conference (the “Board Meeting”). The seven members of the Company’s Board of Directors (the “Board”) include Ian James, Stephen Letourneau, Montel Williams, Christina Jefferson, Joseph Watson, David Deming, and Dr. Nicola Finley, MD.
Establishment of Strategic Advisory Committee
The Board unanimously approved the establishment of a Strategic Advisory Committee (the “Committee”). The Committee will be tasked with providing acceleration, reach, and guidance to further enhance the Company’s value proposition and portfolio. The Committee will work closely with the Board and Better For You Wellness leadership and advise on matters relating to the Company’s capital raising efforts, acquisitions, public relations strategy, brand development, international expansion, and more.
Appointment of Committee Members
In addition to the establishment of the Committee, the Board appointed six initial Committee Members by unanimous consent. The Committee is composed of respected industry leaders who bring relevant experience, networks, and leadership to the Company’s various initiatives. These individuals reflect the Company’s vision and dedication to building a global leader in the wellness sector. Committee Members include:
Appointment of Audit Committee Chairperson
By unanimous vote of the Board’s five non-executive Independent Directors, David Deming was appointed Chairperson of the Company’s Audit Committee, which follows the Board’s October 1, 2021, unanimous consent to establish the Audit Committee. The Audit Committee currently consists of three non-executive Independent Directors, including Montel Williams, Joseph Watson, and David Deming.
The Audit Committee was established to meet the up-listing requirements for a national securities exchange such as the NASDAQ or NYSE as soon as practicable, under NASDAQ Listing Rule 5605(c) and/or NYSE Listed Company Manual Sections 303A.06 and 303A.07.
New Compensation Committee Member and Appointment of Compensation Committee Chairperson
Also, by unanimous vote of the Board’s five non-executive Independent Directors, Christina Jefferson was appointed to the Company’s Compensation Committee, filling the vacancy left by former Director Leslie Bumgarner. This action follows the Board’s October 1, 2021, unanimous consent to establish the Compensation Committee. The Compensation Committee currently consists of Independent Directors, Christina Jefferson, Montel Williams, and Joseph Watson. Additionally, the Board’s five non-executive Independent Directors unanimously appointed Joseph Watson as Chairperson of the Compensation Committee.
The Compensation Committee was established to meet the up-listing requirements for a national securities exchange such as the NASDAQ or NYSE as soon as practicable, under NASDAQ Listing Rule 5605(d) and/or NYSE Listed Company Manual Section 303A.05.
Other Company Initiatives
In addition to the aforementioned corporate governance initiatives, the Board celebrated the Company’s recent uplisting to the OTCQB, reviewed the status of existing LOIs, discussed audits and other due diligence-related aspects of each pending acquisition, and estimated the internal timing of their respective Definitive Agreements.
“I welcome the six initial members of the Company’s newly formed Strategic Advisory Committee, and applaud the non-executive Independent Directors’ appointments to the Audit and Compensation Committees,” commented Ian James, Chief Executive Officer of Better For You Wellness Inc. “With Christina’s vast experience in human capital, diversity, equity, and inclusion – her appointment to the Compensation Committee will offer a tremendous advantage to the Company. Furthermore, the appointments of David Deming and Joe Watson as the respective Audit and Compensation Committee Chairpersons bolsters BFYW’s corporate governance.”
About Better For You Wellness, Inc.
Better For You Wellness, Inc. (OTCQB: BFYW) is a Columbus, Ohio-based Company pursuing a dual buy-and-build model within the wellness industry. Better For You Wellness, Inc., through its wholly-owned subsidiary, builds and operates digitally-native, mission-driven brands within the clean beauty sector, including Better Suds. Better For You Wellness, Inc. is also under LOI to acquire three different companies within the clean and natural beauty category. Learn more at https://BFYW.com.
Contact:
Better For You Wellness, Inc.
Ian James, CEO
investors@bfyw.com
Forward-Looking Statements
This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could,” “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company’s reports filed with SEC (https://www.sec.gov/).
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/113453
Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…
MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…
SKYSCRAPER-06 evaluating tiragolumab plus Tecentriq and chemotherapy did not meet the primary endpoints of progression-free…
ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 04, 2024 (GLOBE NEWSWIRE) -- HUTCHMED…